Twenty-five years after Hodgkin lymphoma treatment at what is now Atrium Health Levine Cancer, television and awards show ...

Circulating tumor DNA predicts recurrence and splits disease into two subgroups of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity. A Stanford Medicine-led, ...

Adults who beat Hodgkin lymphoma and made it past the five-year mark still died at nearly twice the rate expected for the general US population, according to a new analysis of more than 20,000 ...

Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen. This is compared to 83% ...

Hodgkin's lymphoma (HL), impacting the lymph nodes and lymphatic system, has experienced a gradual increase in survival rates thanks to contemporary chemotherapy. However, challenges persist for ...

Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial We performed ...

Lymphomas, cancers that arise in the infection-fighting cells of the immune system, rarely make headlines the way breast or lung cancer do, yet they impose a growing and unevenly distributed burden in ...

Green, 43, announced his diagnosis in a YouTube video Friday morning. He said he had been diagnosed with the disease after noticing enlarged lymph nodes. He explained the cancer is considered very ...

Survivors of hematologic cancers are at high risk of developing cardiovascular disease (CVD), according to a study published online June 22 in BMC Cancer. For the first time, Weill Cornell Medicine ...